Mr. NianWang | Machine Learning | Best Researcher Award

Posted on by sciencefather

Mr. NianWang | Machine Learning | Best Researcher Award 🏆

Xi’an Research Institute of High-tech, Xi ‘an, Shaanxi, China🎓

Nian Wang is a dedicated PhD candidate at the Xi’an Research Institute of High-tech in Xi’an, China. Specializing in machine learning and deep learning applications, Nian has established himself as a promising researcher, with extensive experience as a journal reviewer for prominent IEEE publications.

 

Professional Profile 

  • google scholar

Education 🎓:

Nian Wang is currently pursuing a PhD at the Xi’an Research Institute of High-tech, specializing in advanced machine learning techniques.

Work Experience 💼:

As a PhD candidate, Nian is actively engaged in cutting-edge research and has gained valuable experience through serving as a reviewer for prominent journals such as IEEE Transactions on Image Processing and Pattern Recognition.

 

Skills 🔍:

Nian possesses expertise in deep learning, data clustering, image enhancement, and object recognition. His skills in developing innovative solutions for complex image processing problems have been demonstrated through his research contributions.

Awards and Honors 🏆:

In 2022, Nian received the Excellent Doctoral Dissertation award from the China Ordnance Industry Society, recognizing his significant academic contributions.

Memberships 🤝:

Currently, Nian holds no formal memberships in professional organizations, focusing primarily on his research and academic contributions.

Teaching Experience 👩‍🏫:

While there are no formal teaching roles mentioned, his involvement in research and peer review indicates a strong understanding of academic concepts, which can translate into potential future teaching opportunities.

Research Focus 🔬:

Nian’s research is centered on machine learning applications, particularly in data clustering, image dehazing, and UAV object tracking. His innovative work includes developing the Capsule Attention Network (CAN) for hyperspectral image classification, showcasing improved performance and reduced computational burden compared to existing methods.

Conclusion 

In conclusion, Nian Wang is a highly suitable candidate for the Best Researcher Award due to his innovative contributions, recognized expertise, and commitment to advancing research in machine learning. His achievements speak volumes about his potential for future advancements in the field. By addressing areas for improvement, Nian can enhance his profile further, positioning himself as a leader in research and innovation. Awarding him this honor would not only recognize his past accomplishments but also encourage his continued contributions to the scientific community.

📚 Publilcation 

 

Joanna Jazowiecka-Rakus | oncolytic virotherapy | Best Researcher Award

Posted on by sciencefather

Joanna Jazowiecka-Rakus | oncolytic virotherapy | Best Researcher Award🏆


Assistant Professor at Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Poland
🎓

Joanna Jazowiecka-Rakus is an Assistant Professor with a strong focus on advancing cancer research through innovative oncolytic therapies. Her work at the Maria Skłodowska Memorial National Institute of Oncology in Gliwice, Poland, positions her as a leading expert in experimental cancer treatments. Dr. Jazowiecka-Rakus’s pioneering research in oncolytic virotherapy and nanocarrier drug delivery aims to address complex cancers like pancreatic adenocarcinoma, glioma, and melanoma. With a reputation for pushing boundaries in cancer treatment, she continues to make strides in developing therapies that offer new hope for patients with challenging diagnoses.

Professional Profile 

🎓 Education

Dr. Jazowiecka-Rakus holds a Master of Science in Biology from the Faculty of Biology, University of Silesia, Katowice, Poland (2001), followed by a Ph.D. in Medical Biology from the National Institute of Oncology, Warsaw, Poland (2007). In recognition of her exceptional contributions to cancer research, she earned a D.Sc. (habilitation) in Medical Sciences from the same institution. Her academic path reflects her dedication to enhancing cancer treatment through rigorous scientific training and specialization.

🏢 Work Experience

Throughout her career, Dr. Jazowiecka-Rakus has held esteemed research positions, including her current role as an Assistant Professor at the National Institute of Oncology. Her work has been instrumental in projects funded by prestigious institutions like the International Center for Genetic Engineering and Biotechnology and the National Science Center of Poland. Notably, her research covers a wide spectrum of experimental cancer therapies, including the use of myxoma viruses and mesenchymal stem cells to treat melanoma, ovarian cancer, and glioma. She has also forged valuable collaborations with global institutions, such as the Biodesign Institute at the University of Arizona, Tempe, USA.

🧬 Skills

Dr. Jazowiecka-Rakus brings a wealth of expertise in cancer treatment, highlighted by her skills in oncolytic virotherapy, cancer immunotherapy, and advanced drug delivery systems. Her work with oncolytic virotherapy focuses on developing viral therapies that specifically target and destroy cancer cells, offering a promising alternative to traditional cancer treatments. In cancer immunotherapy, she integrates immune-enhancing agents to create therapies for advanced cancers. Her pioneering methods for stem cell-based drug delivery use mesenchymal stem cells as carriers for oncolytic viruses, targeting tumor cells more effectively. Additionally, she has developed nanocarrier drug formulations that improve the delivery and efficacy of drugs in cancer treatment.

Awards and Honors 🏆

Dr. Jazowiecka-Rakus’s dedication to cancer research has earned her numerous accolades. Between 2017 and 2020, she was awarded a research grant by the International Center for Genetic Engineering and Biotechnology to study oncolytic melanoma therapy, underlining her impact in this vital area. Her scholarly contributions include 18 articles published in high-impact journals indexed in Web of Science and Scopus, reflecting her influence and recognition within the cancer research community. Her works have accumulated a citation index of over 431, showcasing the significant reach and impact of her research.

🌐 Memberships

Active in professional societies, Dr. Jazowiecka-Rakus is an auditor for the Association for the Support of Cancer Research in Gliwice, Poland, where she contributes to promoting research integrity and supporting advancements in cancer studies. She is also a member of the Polish Radiation Research Society based in Warsaw, where she engages with other professionals dedicated to improving cancer treatment and sharing knowledge within the field.

📚 Teaching Experience

As an Assistant Professor, Dr. Jazowiecka-Rakus is committed to educating and mentoring the next generation of cancer researchers at the National Institute of Oncology. Her teaching covers essential aspects of oncology and medical biology, with a particular focus on innovative treatment strategies in cancer research. Through her courses and mentoring, she guides students in understanding the complexities of cancer treatment, encouraging them to pursue research that makes a real-world impact.

🔬 Research Focus

Dr. Jazowiecka-Rakus’s research centers on developing experimental therapies for aggressive cancers. Her work includes the creation of oncolytic myxoma virus constructs, which use mesenchymal stem cells as carriers to deliver viral therapies specifically targeting cancers such as pancreatic adenocarcinoma and glioma. She has developed advanced blood-brain barrier crossing techniques to treat glioma through intra-arterial delivery, offering a new method to target brain tumors effectively. Additionally, her research on 3D models for cancer uses spheroid and organoid models to test therapies for disseminated ovarian cancer, pushing the boundaries of cancer treatment with innovative laboratory models that mimic real-world conditions. Dr. Jazowiecka-Rakus’s interdisciplinary approach highlights her dedication to advancing the field of cancer therapy and improving patient outcomes.

Conclusion 

In conclusion, Dr. Joanna Jazowiecka-Rakus exemplifies the qualities of an outstanding researcher through her innovative projects, significant contributions to cancer research, and a strong academic foundation. Her ongoing work and potential for future advancements make her a deserving candidate for the Best Researcher Award. Enhancing her publication record and pursuing patent opportunities would further solidify her standing as a leader in the field.

📚 Publilcation 

  • Adipose-Derived Stem Cells as Carrier of Pro-Apoptotic Oncolytic Myxoma Virus: To Cross the Blood–Brain Barrier and Treat Murine Glioma
  • Combination of LIGHT (TNFSF14)-Armed Myxoma Virus Pre-Loaded into ADSCs and Gemcitabine in the Treatment of Experimental Orthotopic Murine Pancreatic Adenocarcinoma
  • Myxoma Virus Expressing LIGHT (TNFSF14) Pre-Loaded into Adipose-Derived Mesenchymal Stem Cells Is Effective Treatment for Murine Pancreatic Adenocarcinoma
  • Removal of Heavy Metal Ions from Wastewaters: An Application of Sodium Trithiocarbonate and Wastewater Toxicity Assessment
  • COVID-19 Autopsies: A Case Series from Poland
  • Myxoma Virus-Loaded Mesenchymal Stem Cells in Experimental Oncolytic Therapy of Murine Pulmonary Melanoma
  • Mesenchymal stem cells as carriers for systemic delivery of oncolytic viruses

 

Hussein Al-Hakeim | Neuroscience | Best Researcher Award

Posted on by sciencefather

Prof Hussein Al-Hakeim | Neuroscience | Best Researcher Award 🏆

Peofessor of Medical Biochemistry at University of Kufa, Iraq🎓

 Professor Dr. Hussein Kadhem Al-Hakeim is a distinguished Iraqi academic specializing in Medical Biochemistry, Biological Psychiatry, Insulin Resistance, and Nanobiochemistry. Residing at 28 Al-Adala, Najaf, Iraq, he is currently affiliated with Kufa University. Dr. Al-Hakeim is well-recognized for his significant contributions to biochemistry and clinical chemistry in Iraq.

Professional Profile 

Education🎓

Dr. Al-Hakeim earned his B.Sc. in Chemistry from the University of Mosul in 1991, followed by an M.Sc. in Medical Chemistry and a High Graduate Diploma in Clinical Biochemistry from Al-Nahrain University in 2000 and 2001, respectively. He completed his Ph.D. in Medical Chemistry at the same institution in 2004. Additionally, he holds a Diploma in International Law and Diplomatic Relations from Cairo Regional Center for Training and Arbitration, obtained in 2017.

 💼Work Experience

Dr. Al-Hakeim has held various leadership roles, including Head of the Department of Chemistry at Kufa University and the University of Karbala. He has served as the Assistant Dean and Chief of the Examination Committee at the College of Science, University of Karbala. His teaching career includes extensive experience as a lecturer in postgraduate studies across multiple universities in Iraq.

 🛠️Skills

Dr. Al-Hakeim is an expert in Medical and Clinical Biochemistry, Nanobiochemistry, Insulin Resistance, and Stem Cell Technology. He has a profound knowledge of biostatistics, biosensors, and protein-nanoparticle interactions, and is skilled in advanced laboratory techniques and various biochemical analysis methods.

 🏆Awards and Honors

Dr. Al-Hakeim’s work has been recognized at numerous scientific congresses and conferences worldwide. His research contributions and academic leadership have earned him a prominent place in Iraq’s scientific community.

 Membership 🏛️and Affiliations 🤝

Dr. Al-Hakeim is an active member of several scientific committees and associations. He frequently participates in international conferences and has presented his research at numerous prestigious events.

 Teaching Experience👨‍🏫

Dr. Al-Hakeim has taught a wide range of courses at the B.Sc., M.Sc., and Ph.D. levels. His subjects include Advanced Biochemistry, Clinical Biochemistry, Toxicology, Endocrinology, Biostatistics, and more. He has also coordinated several courses and training programs, contributing significantly to the academic development of his students.

 Research Focus 🔬

Dr. Al-Hakeim’s research interests encompass Medical Biochemistry, Clinical Chemistry, Insulin Resistance Mechanisms, Stem Cell Technology, Nanobiochemistry, and the Medical Applications of Surface Chemistry. His work is particularly focused on protein-nanoparticle interactions, a field where he has made substantial contributions.

📖Publications : 

  • IL-6, IL-18, sIL-2R, and TNFα proinflammatory markers in depression and schizophrenia patients who are free of overt inflammation
    • 🗓️ Year: 2015
    • 📚 Journal: Journal of Affective Disorders
  • Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses, and inflammation: a proof of concept
    • 🗓️ Year: 2023
    • 📚 Journal: Molecular Psychiatry
  • Study of the effect of iron overload on the function of endocrine glands in male thalassemia patients
    • 🗓️ Year: 2011
    • 📚 Journal: Asian Journal of Transfusion Science
  • Intersections between pneumonia, lowered oxygen saturation percentage, and immune activation mediate depression, anxiety, and chronic fatigue syndrome-like symptoms due to COVID
    • 🗓️ Year: 2021
    • 📚 Journal: Journal of Affective Disorders
  • The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments
    • 🗓️ Year: 2022
    • 📚 Journal: Molecular Psychiatry
  • The tryptophan catabolite or kynurenine pathway in COVID-19 and critical COVID-19: a systematic review and meta-analysis
    • 🗓️ Year: 2022
    • 📚 Journal: medRxiv
  • Serum levels of lipids, calcium, and magnesium in women with hypothyroidism and cardiovascular diseases
    • 🗓️ Year: 2009
    • 📚 Journal: Journal of Laboratory Physicians
  • High Mobility Group Protein 1 and Dickkopf-Related Protein 1 in Schizophrenia and Treatment-Resistant Schizophrenia: Associations With Interleukin-6, Symptom Domains, and…
    • 🗓️ Year: 2020
    • 📚 Journal: Schizophrenia Bulletin
  • IL-10 is associated with increased mu-opioid receptor levels in major depressive disorder
    • 🗓️ Year: 2019
    • 📚 Journal: European Psychiatry
  • Lowered oxygen saturation and increased body temperature in acute COVID-19 largely predict chronic fatigue syndrome and affective symptoms due to Long COVID: A precision…
    • 🗓️ Year: 2023
    • 📚 Journal: Acta Neuropsychiatrica
  • The physio-affective phenome of major depression is strongly associated with biomarkers of astroglial and neuronal projection toxicity which in turn are associated with…
    • 🗓️ Year: 2023
    • 📚 Journal: Journal of Affective Disorders
  • Serum interleukin levels and insulin resistance in major depressive disorder
    • 🗓️ Year: 2018
    • 📚 Journal: CNS & Neurological Disorders – Drug Targets
  • Lowered quality of life in long COVID is predicted by affective symptoms, chronic fatigue syndrome, inflammation, and neuroimmunotoxic pathways
    • 🗓️ Year: 2022
    • 📚 Journal: International Journal of Environmental Research and Public Health
  • Schizophrenia phenomenology revisited: positive and negative symptoms are strongly related reflective manifestations of an underlying single trait indicating overall severity…
    • 🗓️ Year: 2020
    • 📚 Journal: CNS Spectrums
  • The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: A systematic review and meta-analysis
    • 🗓️ Year: 2022
    • 📚 Journal: Brain, Behavior, & Immunity – Health
  • The neuroimmune and neurotoxic fingerprint of major neurocognitive psychosis or deficit schizophrenia: a supervised machine learning study
    • 🗓️ Year: 2020
    • 📚 Journal: Neurotoxicity Research
  • Serum apelin and galectin-3 in preeclampsia in Iraq
    • 🗓️ Year: 2020
    • 📚 Journal: Hypertension in Pregnancy
  • Construction of a Neuro-Immune-Cognitive Pathway-Phenotype Underpinning the Phenome of Deficit Schizophrenia
    • 🗓️ Year: 2020
    • 📚 Journal: Current Topics in Medicinal Chemistry
  • Estimation of Serum Copper, Manganese, Selenium, and Zinc in Hypothyroidism Patients
    • 🗓️ Year: 2009
    • 📚 Journal: IUFS Journal of Biology
  • Major depression in children with transfusion-dependent thalassemia is strongly associated with the combined effects of blood transfusion rate, iron overload, and increased pro…
    • 🗓️ Year: 2020
    • 📚 Journal: Neurotoxicity Research

Achilleia-Maria Pavlou | Medicine and Dentistry | Best Researcher Award

Posted on by sciencefather

 Dr. Achilleia-Maria Pavlou | Medicine and Dentistry | Best Researcher Award

 Dr.Achilleia-Maria Pavlou,School of Dentistry, Aristotle University of Thessaloniki, Greece,Greece

 

Dr. Achilleia-Maria Pavlou is a distinguished academic at the School of Dentistry, Aristotle University of Thessaloniki, Greece. With a focus on advancing dental science and clinical practices, she has made significant contributions to her field through research, teaching, and professional development. Her expertise and commitment to dentistry are reflected in her ongoing efforts to improve patient care and educational outcomes within the dental community.

Professional Profile:

Academic and Professional Background:

I hold a DDS, MD, and MSc degrees, with a postgraduate thesis on the “Isolation and characterization of stem cells from minor salivary glands of the oral mucosa and their differentiation into insulin-producing pancreatic cells.” Currently, I am pursuing a PhD focusing on the molecular pathways of pancreatic differentiation in minor salivary gland stem cells. My academic journey includes a two-year residency in pathology and plans for a four-year residency in rheumatology.

Research and Innovations:

  • Daylight Photodynamic Therapy: Successfully completed a project exploring its efficacy in treating actinic cheilitis.
  • Pancreatic Differentiation: Ongoing research on the potential of minor salivary gland stem cells to differentiate into insulin-producing pancreatic cells.

Areas of Research:

  • Photodynamic therapy
  • Daylight photodynamic therapy
  • Actinic cheilitis
  • Human minor salivary gland stem cells
  • Pancreatic differentiation

Contributions:

  • My research has demonstrated that daylight photodynamic therapy can serve as a primary treatment for actinic cheilitis with grade I dysplasia, showing complete clinical response with minimal adverse effects. Additionally, my work has established the potential of minor salivary gland stem cells for pancreatic differentiation, which could advance diabetes mellitus treatments.

Publications: 

  • Andreadis D, Pavlou AM, Sotiriou E, Vrani F, Ioannides D, Kolokotronis A. “Utility of photodynamic therapy for the management of oral potentially malignant disorders and oral cancer.” Translational Research in Oral Oncology, 2016; 1: 1–19. DOI

 

  • Matiakis A, Karakostas P, Pavlou AM, Anagnostou E, Poulopoulos A. “Angioleiomyoma of the oral cavity: a case report and brief review of the literature.” J Korean Assoc Oral Maxillofac Surg., 2018; 44(3): 136-139. DOI

 

  • Andreadis D, Pavlou AM, Vakirlis E, Anagnostou E, Vrani F, Poulopoulos A, Kolokotronis A, Ioannidis D, Sotiriou E. “Daylight photodynamic therapy for the management of actinic cheilitis.” Arch Dermatol Res., 2020; 312(10): 731-737. DOI

 

  • Andreadis D, Pavlou AM, Vakirlis E, Anagnostou E, Vrani F, Poulopoulos A, Kolokotronis A, Ioannidis D, Sotiriou E. “Actinic cheilitis may resemble oral lichenoid-type lesions or discoid lupus erythematosus.” Arch Dermatol Res., 2021; 313(10): 891-892. DOI

 

  • Pavlou AM, Papachristou E, Bonovolias I, Anagnostou E, Anastasiadou P, Poulopoulos A, Bakopoulou A, Andreadis D. “Pancreatic Differentiation of Oral Minor Salivary Gland Stem Cells.” Stem Cell Rev Rep., 2024. DOI